Urol. praxi. 2021;22(2):70-74 | DOI: 10.36290/uro.2021.022

Modern trends in prophylaxis of lower urinary tract infections

MUDr. Hana Musilová, MUDr. Roman Staněk
Urologické oddělení, Slezská nemocnice v Opavě

Urinary tract infections are very frequent diagnose among bacterial infections. Illness mostly affect women than men (20:1). Prophylaxis lower urinary tract infections is provided by antimicrobial or non-antimicrobial ways. Regarding to increased antibiotics resistance of bacterial strains, modern medicine tend to looking for new non-antimictobial ways of prophylaxis of lower urinary tract infections and decrease frequency of using antibiotic therapy.

Keywords: uroinfection, vulvovaginal discomfort, cranberries, D-mannose, hyaluronic acid, probiotics, immunostimulation, enzymatic therapy.

Received: May 9, 2021; Revised: May 9, 2021; Accepted: May 20, 2021; Prepublished online: May 20, 2021; Published: June 2, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Musilová H, Staněk R. Modern trends in prophylaxis of lower urinary tract infections. Urol. praxi. 2021;22(2):70-74. doi: 10.36290/uro.2021.022.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Beneš J, et. al. Infekční lékařství. 1. vyd. Praha; Galén 2009; ISBN 978-80-7262-644-1; 480-483.
    2. Halaška M, et al. Urogynekologie, 1. vyd. Praha; Galén 2004; ISBN 90-7262-272-2; 63-68.
    3. Abdullatif A, Kamran A, Iftikhar Z, et al. Recurrent urinary tract infections in women, Int Urogynecol J 2015; 26(6): 795-804. https://pubmed.ncbi.nlm.nih.gov/25410372/. Go to original source... Go to PubMed...
    4. Poršová M, Kolombo I, Porš J, et al. Možnosti prevence recidivujících infekcí močových cest. Urol. praxi 2006; 5: 204-209.
    5. Zámečník L, et al. Moderní farmakoterapie v urologii. 1. vyd. Praha; Maxdorf 2019; ISBN 978-80-7345-609-2; 11-20.
    6. Špaček J, Buchta V, Jílek P, et al. Vulvovaginální dyskomfort a poruchy poševního prostředí. 1. vyd. Praha; Grada 2013. ISBN 978-80-247-4554-1; 93-97.
    7. Čepický P. Vulvovaginitidy pro urogynekology. Urol. praxi 2018; 19(3): 111-11. Go to original source...
    8. González de Llano D, Victoria Moreno-Arribas M, Bartolomé B. Cranberry Polyphenols and Prevention against Urinary Tract Infections: Relevant Considerations; Molecules. 2020; 25(15): 3523. Published online 2020 Aug 1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436188/. Go to original source... Go to PubMed...
    9. Bonkat G, Bartoletti R, Bruyère F, et al. EAU Guidelines on Urological Infections, European Association of Urology 2021; http://www.uroweb.org/.
    10. Franssen M, et al. D-MannosE to prevent Recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial; BMJ Open 2021; 11: e037128; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812098/. Go to original source... Go to PubMed...
    11. Kranjcec B, et al. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol 2014; 32: 7. https://pubmed.ncbi.nlm.nih.gov/23633128/. Go to original source... Go to PubMed...
    12. Iavazzo C, Athanasiou S, Pitsouni E, et al. Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? Eur Urol. 2007; 51: 1534-41. https://pubmed.ncbi.nlm.nih.gov/17383810/. Go to original source... Go to PubMed...
    13. Goddard JC, Janssen D. AW. Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis. https://pubmed.ncbi.nlm.nih.gov/29181550/.
    14. Solař S. Prebiotika a probiotika v klinické praxi. Med. Pro Praxi 2010; 7(1): 14-18. www.medicinapropraxi.cz.
    15. Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev 2015; (12). https://pubmed.ncbi.nlm.nih.gov/26695595/. Go to original source... Go to PubMed...
    16. Brodie A, El-Taji O, Jour I, et al. A Retrospective Study of Immunotherapy Treatment with Uro-Vaxom (OM-89®) for Prophylaxis of Recurrent Urinary Tract Infections; Curr Urol 2020; 14(3): 130-134. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659410/. Go to original source... Go to PubMed...
    17. Bauer HW, Rahlfs VW, Lauener PA, et al. Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies; Int J Antimicrob Agents 2002; 19(6): 451-456. https://pubmed.ncbi.nlm.nih.gov/12135831/. Go to original source... Go to PubMed...
    18. Aziminia N, Hadjipavlou M, Philippou Y, et al. Vaccines for the prevention of recurrent urinary tract infections: a systematic review: BJU Int 2018: 754-758. Go to original source... Go to PubMed...
    19. Beerepoot MAJ, Geerlings SE, van Haarst EP, et al. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013; 190(6): 1981-1989. doi: 10.1016/j.juro.2013.04.142. Epub 2013 Jul 15. https://pubmed.ncbi.nlm.nih.gov/23867306/. Go to original source... Go to PubMed...
    20. Bystroň J. Bakteriální imunomodulátory - současné použití v klinické praxi. Remedia 2010; 20(5): 298-304.
    21. Georgescu C, Boboc F, Iancu L, et al. Immunotherapy with autovaccines in urinary tract infections caused by gram-negative bacteria; Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; Apr-Jun 1982; 27(2): 109-19. https://pubmed.ncbi.nlm.nih.gov/7146757/.
    22. Nouza K. Systémová enzymoterapie v urologické praxi; Urol. praxi 2012; 13(5): 214-217.
    23. Kuz'menko AV, Kuz'menko VV, Gyaurgiev TA. Systemic enzyme therapy for treatment of women with chronic recurrent bacterial cystitis. Urologiia 2020; (2): 35-40. https://pubmed.ncbi.nlm.nih.gov/32351061/.
    24. Kladenský J. Nekomplikované infekce dolních močových cest u žen - možnosti léčby a prevence. Urol. praxi 2018; 19(1): 10-15. Go to original source...
    25. Wawrysiuk S, Naber K, Rechberger T, et al. Prevention and treatment of uncomplicated lower urinary tract infections in the era of increasing antimicrobial resistance - non-antibiotic approaches: a systemic review. Arch Gynecol Obstet. 2019; 300(4): 821-828. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759629/. Go to original source... Go to PubMed...
    26. Fraile B, Alcover J, Royuela M, Rodríguez D, et. al. Xyloglucan, hibiscus and propolis for the prevention of urinary tract infections: results of in vitro studies. Future Microbiol. 10.2217/fmb-2017-0015.
    27. Servi B, Ranzini F, Piqué N. Effect of Utipro® (containing gelatinxyloglucan) against Escherichia coli invasion of intestinal epithelial cells: results of an in vitro study. Future Microbiol. 10.2217/fmb-2016-0022.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.